With the U.S. election in the rearview mirror, we have arrived at a defining moment for the future of medical innovation.Drug developers, investors, and biotech entrepreneurs face a policy landscape in the U.S. that many in the industry believe could be improved, in order to hasten the development of new medicines for patients in need. […]
